Wang et al., 2014)
La notable reduccin de peso asociada a los frmacos recientemente desarrollados y aprobados sigue siendo de inters para los mdicos que abordan la epidemia de obesidad generalizada
[DOI] [PubMed] [Google Scholar] 44.Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, Investigators V Glucose control and vascular complications in veterans with type 2 diabetes
The peptide incorporates a C20 fatty diacid moiety via a Glu-Glu linker enabling reversible albumin binding and an extended pharmacokinetic profile compatible with once-weekly dosing
The ingredient for pH adjustment of products